122 related articles for article (PubMed ID: 1909103)
1. Effects of gamma radiation and azathioprine on Brucella abortus infection in BALB/c mice.
Elzer PH; Rowe GE; Enright FM; Winter AJ
Am J Vet Res; 1991 Jun; 52(6):838-44. PubMed ID: 1909103
[TBL] [Abstract][Full Text] [Related]
2. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus.
Araya LN; Elzer PH; Rowe GE; Enright FM; Winter AJ
J Immunol; 1989 Nov; 143(10):3330-7. PubMed ID: 2509555
[TBL] [Abstract][Full Text] [Related]
3. Resistance of Brucella abortus infected mice to intravenous or intraperitoneal Brucella reinfection.
Pardon P; Marly J
Ann Immunol (Paris); 1976; 127(1):57-70. PubMed ID: 821385
[TBL] [Abstract][Full Text] [Related]
4. Macrophages and Brucella.
Baldwin CL; Winter AJ
Immunol Ser; 1994; 60():363-80. PubMed ID: 8251581
[TBL] [Abstract][Full Text] [Related]
5. Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells.
Briones G; Iñón de Iannino N; Roset M; Vigliocco A; Paulo PS; Ugalde RA
Infect Immun; 2001 Jul; 69(7):4528-35. PubMed ID: 11401996
[TBL] [Abstract][Full Text] [Related]
6. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
[TBL] [Abstract][Full Text] [Related]
7. Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19.
Elzer PH; Jacobson RH; Jones SM; Nielsen KH; Douglas JT; Winter AJ
Immunology; 1994 Aug; 82(4):651-8. PubMed ID: 7835931
[TBL] [Abstract][Full Text] [Related]
8. Protection of mice against Brucella abortus infection by inoculation with monoclonal antibodies recognizing Brucella O-antigen.
Phillips M; Deyoe BL; Canning PC
Am J Vet Res; 1989 Dec; 50(12):2158-61. PubMed ID: 2481994
[TBL] [Abstract][Full Text] [Related]
9. Effects of exogenous recombinant interleukin-12 on immune responses and protection against Brucella abortus in a murine model.
Lee IK; Olsen SC; Bolin CA
Can J Vet Res; 2001 Oct; 65(4):223-8. PubMed ID: 11768128
[TBL] [Abstract][Full Text] [Related]
10. Immunogencity of HSA-L7/L12 (Brucella abortus ribosomal protein) in an animal model.
Pakzad I; Rezaee A; Rasaee MJ; Tabbaraee B; Delpisheh A
Iran J Immunol; 2009 Mar; 6(1):12-21. PubMed ID: 19293473
[TBL] [Abstract][Full Text] [Related]
11. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
[TBL] [Abstract][Full Text] [Related]
13. Persistence of Brucella abortus in the livers of T cell-deficient nude mice.
Cheville NF; Kunkle RA; Jensen AE; Palmer MV
Lab Invest; 1995 Jul; 73(1):96-102. PubMed ID: 7603046
[TBL] [Abstract][Full Text] [Related]
14. The immunomodulatory effect of antimicrobial peptide HPA3P restricts Brucella abortus 544 infection in BALB/c mice.
Arayan LT; Kim HB; Bernardo Reyes AW; Xuan Huy NT; Hong IH; Lee K; Yeom JH; Park Y; Kim S
Vet Microbiol; 2018 Nov; 225():17-24. PubMed ID: 30322527
[TBL] [Abstract][Full Text] [Related]
15. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
16. Identification of a virulence factor for Brucella abortus infection in BALB/c mice.
Pugh GW; Tabatabai LB; Bricker BJ; Mayfield JE; Phillips M; McDonald TJ; Zehr ES
Am J Vet Res; 1989 Jun; 50(6):887-92. PubMed ID: 2504086
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Brucella-susceptible mice with IL-12 increases primary and secondary immunity.
Sathiyaseelan J; Goenka R; Parent M; Benson RM; Murphy EA; Fernandes DM; Foulkes AS; Baldwin CL
Cell Immunol; 2006 Sep; 243(1):1-9. PubMed ID: 17184756
[TBL] [Abstract][Full Text] [Related]
18. Outcome and immune responses after Brucella abortus infection in young adult and aged mice.
High KP; Prasad R; Marion CR; Schurig GG; Boyle SM; Sriranganathan N
Biogerontology; 2007 Oct; 8(5):583-93. PubMed ID: 17653832
[TBL] [Abstract][Full Text] [Related]
19. Experimentally induced Brucella abortus infection in pregnant goats.
Meador VP; Deyoe BL
Am J Vet Res; 1986 Nov; 47(11):2337-42. PubMed ID: 3098143
[TBL] [Abstract][Full Text] [Related]
20. An aerosolized Brucella spp. challenge model for laboratory animals.
Olsen SC; Waters WR; Stoffregen WS
Zoonoses Public Health; 2007; 54(8):281-5. PubMed ID: 17894637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
